Clinical Trial Update: Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effects of cross-titrating antipsychotics with ziprasidone in schizophrenia or schizoaffective disorder; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia, Psychotic Disorders | Phase 4 | Status: COMPLETED